Update on the research of diabetic dyslipidemia
10.3760/cma.j.issn.1000-6699.2012.09.003
- VernacularTitle:糖尿病血脂异常研究新进展
- Author:
Li YAN
;
Chuan WANG
- Publication Type:Journal Article
- Keywords:
Diabetes mellitus;
Cardiovascular disease;
Dyslipidemia
- From:
Chinese Journal of Endocrinology and Metabolism
2012;28(9):704-709
- CountryChina
- Language:Chinese
-
Abstract:
Dyslipidemia is one of the major risk factors for cardiovascular disease in diabetes mellitus,but clinical practices in the management of diabetic dyslipidemia are still not satisfactory in China.The cornerstone of treatment for diabetic dyslipidemia consists of therapeutic lifestyle change and statins.Recent guidelines emphasize aggressive low density lipoprotein-cholesterol control with statins.However,intensive statin therapy may increase the risk of myopathy and diabetes.Therefore,it is important to consider its risk benefit ratio in individual patients.The additional benefit of statins in combination with other hypolipidemic drugs on cardiovascular risk needs verifying by further investigation.
